EyeVinci B.V. Competitors

Optomed is a Finnish medical technology company and a leading provider of handheld fundus cameras. Optomed combines handheld fundus cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye diseases such as rapidly increasing diabetic retinopathy. Optomed was founded in Oulu, Finland in 2004 by Seppo Kopsala Optomed’s CEO, with the vision to design and produce a smaller and more affordable fundus camera than traditionally used desktop cameras, which would improve the efficiency of the eye screening of diabetics. In the early years, the operations were focused on research and development with a long-term perspective and sales activities were limited. At the beginning of the journey, Optomed developed three early product generations. In 2013, Optomed reached a major milestone when it launched the world’s first handheld fundus camera meeting the fundus camera standard ISO 10940 resolution requirements, Smartscope PRO. In 2017, Optomed launched its fifth handheld fundus camera generation, Optomed Aurora.

We are a digital health software company from the Ruhr region, located on the Health Campus in Bochum. Our innovative products and solutions play a key role in advancing the digitalization and connectivity of the healthcare industry. Our award-winning software solution for radiological image reporting, JiveX Enterprise PACS, is the market leader in Germany. Having achieved global success, VISUS’s software products are now implemented in more than 40 countries. Another key area of our expertise is the comprehensive management of medical data across healthcare facilities. All JiveX solutions from VISUS are characterized by an open and standardized interface architecture that adheres to international standards such as DICOM, IHE, HL7, and FHIR, ensuring high levels of interoperability and scalability. As a subsidiary of CompuGroup Medical SE & Co. KGaA, VISUS is part of one of the world’s leading e-health companies. Imprint: https://www.visus.com/en/imprint.html Privacy policy: https://www.visus.com/en/privacy-policy.html

EyeTech designs and manufactures the EyeOn Home™ — the integrated monolithic AI compute platform that serves as the brains of every Oreqa home energy system. EyeOn Home is not a controller bolted onto a battery. It is a single, custom-engineered platform built around a proprietary AI System-on-Chip that runs the full Oreqa Battery Management System, optimizes the home’s energy production, storage, and consumption in real time, coordinates with the utility for grid services, and — in the same architecture — delivers the most advanced human-interface capability available in any residential energy product. EyeTech was founded in 1996 by a former Boeing engineer who, facing a personal disability, set out to build human-interface technology that returns independence and dignity to the people the rest of the consumer tech industry was not designing for. Three decades of work later, EyeTech holds eight issued U.S. patents and an FDA Class II classification (21 CFR § 890.3710) covering its eye-tracking, speech-generating, and assistive-control platform — a regulatory pedigree that takes years of clinical work and tens of millions of dollars to obtain, and one no other residential energy company possesses. EyeTech is a wholly owned subsidiary of EverPower.AI LLC. Visit www.everpower.ai to explore our full ecosystem of sister companies and offerings.